Comparing classic and newer phenotypes in Greek PCOS women: The prevalence ofmetabolic syndrome and their association with insulin resistance

Journal of Endocrinological Investigation

Volumn 36, Issue 7, 2013, Pages 478-484

  Vaggopoulos, V ^a   Trakakis, E ^a   Chrelias, C ^a   Panagopoulos, P ^a   Basios, G ^a   Makridima, S ^a   Sioulas, V D ^a   Simeonides, G ^a   Labos, G ^a   Boutati, E ^a   Kassanos, D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Insulin resistance; Metabolic syndrome; Phenotypes; Polycystic ovary syndrome

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; DISEASE ASSOCIATION; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PREVALENCE; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX;

ADULT; FEMALE; GLUCOSE TOLERANCE TEST; GREECE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; PREVALENCE; PROSPECTIVE STUDIES; RISK;

EID: 84881446369     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8771     Document Type: Article

References (28)

1. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam G eds. Polycystic ovary syndrome. Boston: Blackwell Scientific. 1992, 377-84.
2. The Rotterdam ESHRE/ASRM sponsored PCOS consensus workshop. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Fertil Steril 2004, 81: 19-26.
3. Azziz R, Carmina E. Diagnosis, phenotype, and prevalence of polycystic ovary syndrome. Fertil Steril 2006, 86: 7-8.
4. Willis D, Franks S. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 1995, 80: 3788-90.
5. Wu S, Divall S, Wondisford F, Wolfe A. Reproductive tissues maintain insulin sensitivity in diet-induced obesity. Diabetes 2012, 61: 114-23.
6. Ferriman D, Gallwey JD. Clinical assessment of body hairgrowth in women. J Clin Endocrinol Metab 1961, 21: 1440-7.
7. Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 2003, 9: 505-14.
8. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner R. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28: 412-9.
9. Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004, 59: 141-54.
10. Rubinstein A. National Cholesterol Education Program, second report of the Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Circulation 1995, 91: 908-9.
11. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22: 1462-70.
12. Hsu MI, Liou TH, Chou SY, Chang CY, Hsu CS. Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990. Fertil Steril 2007, 88: 727-9.
13. Barber TM, Wass JA, McCarthy MI, Franks S. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2007, 66: 513-7.
14. Dewailly D, Catteau-Jonard S, Reyss AC, Leroy M, Pigny P. Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. J Clin Endocrinol Metab 2006, 91: 3922-7.
15. Pehlivanov B, Orbetzova M. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population. Gynecol Endocrinol 2007, 23: 604-9.
16. Chae SJ, Kim JJ, Choi YM, et al. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod 2008, 23: 1924-31.
17. Diamanti-Kandarakis E, Panidis D. Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol (Oxf) 2007, 67: 735-42.
18. Belosi C, Selvaggi L, Apa R, et al. Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? Hum Reprod 2006, 21: 3108-15.
19. Carmina E, Napoli N, Longo RA, Rini GB, Lobo RA. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS. Eur J Endocrinol 2006, 154: 141-5.
20. Anaforoglu I, Algun E, Incecayir O, Ersoy K. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women. Metab Syndr Relat Disord 2011, 9: 375-80.
21. Wijeyaratne CN, Seneviratne Rde A, Dahanayake S, et al. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic. Hum Reprod 2011, 26: 202-13.
22. Kandaraki E, Christakou Ch, Diamanti-Kandarakis E. Metabolic syndrome and polycystic ovary syndrome ... and vice versa. Arq Bras Endocrinol Metab 2009, 53: 227-37.
23. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008, 294: 15-26.
24. Chen H, Sullivan G, Quon MJ. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 2005, 54: 1914-25.
25. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes? Diabetes Care 2007, 30: 1544-8.
26. Panidis D, Tziomalos K, Misichronis G, et al. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod 2012, 27: 541-9.
27. Cascella T, Palomba S, De Sio I, et al. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Hum Reprod 2008, 23: 153-9.
28. Palomba S, Falbo A, Zullo F, Orio F jr. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 2009, 30: 1-50.